Clinical Trial Update: A 15-day Study to Assess the Safety and Clinical Utility of Duragesic (Fentanyl Transdermal Patch) in the Treatment of Children With Continuous Pain Requiring Narcotic Pain Relief Therapy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and clinical utility of Duragesic (fentanyl transdermal patch) in children with chronic pain completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Duragesic (fentanyl transdermal system)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Chronic Pain | Phase 3 | Status: COMPLETED